The biopharmaceuticals sector encompasses a wide range of innovative applications, including monoclonal antibodies (mAbs), gene therapy, cell therapy, antibody-drug conjugates (ADCs), vaccines, and plasma-derived products. This field is essential for advancing next-generation bioprocessing technologies that enhance drug development and manufacturing efficiency. Biotech start-ups can leverage these advancements to find quicker, more effective solutions to their development challenges, significantly speeding up the journey to commercialization. At AREX Biosciences, we are committed to providing the high-quality tools and resources that support researchers and companies in navigating the complexities of biopharmaceutical development.